e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Longitudinal studies of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence of nasal polyposis and its association with the development of chronic bronchitis and/or emphysema
U. Nihlén, P. Montnémery, M. K. Andersson, C. G. Löfdahl, C. G. Persson, L. Greiff (Lund, Sweden)
Source:
Annual Congress 2002 - Longitudinal studies of COPD
Session:
Longitudinal studies of COPD
Session type:
Oral Presentation
Number:
2549
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Nihlén, P. Montnémery, M. K. Andersson, C. G. Löfdahl, C. G. Persson, L. Greiff (Lund, Sweden). Incidence of nasal polyposis and its association with the development of chronic bronchitis and/or emphysema. Eur Respir J 2002; 20: Suppl. 38, 2549
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2001; 17: 596-603
Year: 2001
Chronic bronchitis: a risk factor for bronchial infection
Source: Eur Respir Monogr 2013; 60: 18-26
Year: 2013
Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
The role of the tracheal phonography in chronic obstructive lung disease and asthma diagnosis
Source: Annual Congress 2012 - Asthma management
Year: 2012
Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012
Prevalence of chronic rhinosinusitis in COPD stable patients
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 411s
Year: 2004
Nasal polyposis and risk of the airway‘s inflammation development
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Prevalence and 20-year trends of chronic bronchitis, bronchial obstruction and asthma in Finland
Source: Eur Respir J 2003; 22: Suppl. 45, 117s
Year: 2003
Diagnosing COPD: distinguishing between emphysema and chronic bronchitis
Source: International Congress 2015 – ME1 Diagnosing COPD
Year: 2015
The association of bronchial colonization with the extent of lung lesions in children with non-CF chronic suppurative lung disease or recurrent pneumonia
Source: Annual Congress 2009 - Fiberoptic bronchoscopy in the diagnosis of respiratory diseases in children
Year: 2009
Prevalence of adenomatous colorectal polyp in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Management of chronic airway infection in bronchiectasis
Source: Virtual Congress 2020 – The future of bronchiectasis management
Year: 2020
Exacerbation aetiology and inflammation markers in chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002
Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Source: Eur Respir J 2008; 31: 70-77
Year: 2008
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Resolution of bronchial inflammation during exacerbations of chronic bronchitis relate to changes in bacteriology.
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept